CSTONE PHARMACEUTICALS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.86 HKD | -1.15% |
|
-2.27% | -62.11% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The Company conducts its businesses mainly in domestic market.
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.8044
CNY
Average target price
3.186
CNY
Spread / Average Target
+296.14%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -62.11% | 142M | |
| -3.20% | 103B | |
| +1.74% | 96.56B | |
| +1.72% | 22.61B | |
| -17.72% | 21.18B | |
| -4.50% | 19.07B | |
| -41.75% | 16.53B | |
| -25.19% | 14.46B | |
| +2.24% | 13.25B | |
| +22.16% | 11.1B |
- Stock Market
- Equities
- 2616 Stock
- News CStone Pharmaceuticals
- CStone Pharmaceuticals' : Investigational Cancer Treatment Shows Potential in Phase 1b Trial
